I-Mab

Biotech

I-Mab buys Bridge Health for $3M to strengthen givastomig push

I-Mab has solidified its pivot to givastomig by buying out the owner of an antibody used in the therapy.

James Waldron Jul 17, 2025 8:45am

layoffs

I-Mab lays off 27% of workforce after CLDN18.2 bispecific pivot

Jan 29, 2025 7:56am

U turn turn around refocus pivot street sign

I-Mab pauses Sanofi-partnered prospect to focus on CLDN18.2

Jan 6, 2025 8:34am

parachutes peru

Chutes & Ladders—Gilead's Merdad Parsey goes, Cassava loses CEO

Jul 19, 2024 8:00am

parachute chutes

Lonza lands new CEO—Chutes & Ladders

Apr 5, 2024 8:30am

butterfly monarchs fly bugs wings flutter

I-Mab sheds China footprint to transform into US-based biotech

Feb 7, 2024 8:50am